And earlier this year, when 48-year-old Jake Terry wanted to test the effects of retatrutide, a new but not-yet-approved compound developed by the pharmaceutical giant Eli Lilly, he bought some online and took it to his friends
For most patients managing seasonal allergies, a non-sedating antihistamine is the preferred choice
The average weight loss of patients with a 2.4 mg semaglutide dose reached 9.6% after 12 weeks, 13.8% after six months, and approximately 15% to 20% after a year

The worst thing someone can do is suffer in silence and assume nothing can be done. Suffering in Silence or Secretly Self-Adjusting Many GLP-1 users arent raising their symptoms with anyone, and the survey points to several overlapping reasons why: More than 1 in 5 (22%) feel digestive issues are just the price to pay to stay on the medication 14% are embarrassed to discuss symptoms like diarrhea, gas, and constipation 13% fear their provider will lower their dose or tell them to stop 11% dont want to draw attention to the fact that theyre on a GLP-1 at all For the 11% who are quietly adjusting how they take their medication without telling their provider, the survey points to a population that senses something is wrong or cannot find the right care, so is managing it on their own: 29% suspect they have an underlying condition that hasnt been diagnosed 30% dont believe their doctor would take their symptoms seriously or know how to help 22% looked for help but couldnt find the right kind of support Nobody should feel they have to choose between a medication thats helping them and their day-to-day comfort, said Dr

The medical records did not show how severe the patients hair loss was, how long it lasted, or whether their hair eventually grew back
Impact of GLP-1 Receptor Agonists on Whole-Gut Gastrointestinal Motility Using Wireless Motility Capsule: A Descriptive Single-Center Case Series